UBS Group’s VanEck Vectors Generic Drugs ETF GNRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-660
| Closed | -$15K | – | 7433 |
|
|
2019
Q1 | $15K | Buy |
+660
| New | +$15K | ﹤0.01% | 5738 |
|
|
2017
Q4 | – | Sell |
-50
| Closed | -$1K | – | 7278 |
|
|
2017
Q3 | $1K | Sell |
50
-3,395
| -99% | -$67.9K | ﹤0.01% | 6737 |
|
|
2017
Q2 | $78K | Buy |
3,445
+445
| +15% | +$10.1K | ﹤0.01% | 4442 |
|
|
2017
Q1 | $68K | Hold |
3,000
| – | – | ﹤0.01% | 4430 |
|
|
2016
Q4 | $64K | Sell |
3,000
-32,000
| -91% | -$683K | ﹤0.01% | 4742 |
|
|
2016
Q3 | $848K | Sell |
35,000
-1,050
| -3% | -$25.4K | ﹤0.01% | 2836 |
|
|
2016
Q2 | $860K | Sell |
36,050
-18,950
| -34% | -$452K | ﹤0.01% | 2814 |
|
|
2016
Q1 | $1.32M | Buy |
+55,000
| New | +$1.32M | ﹤0.01% | 2459 |
|